ESC 365 - Do we need trials of combination pharmacotherapy?

HFA Premium Access

Do we need trials of combination pharmacotherapy?

Session: What next for trials in heart failure with preserved ejection fraction?

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Professor N. Sato (Kawaguchi, JP)

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Professor Naoki Sato

Kawaguchi Cardiovascular and Respiratory Hospital, Kawaguchi (Japan)

6 presentations

0 follower

3 more presentations in this session

Similarities and differences between SGLT2i trials in HFpEF

Speaker: Professor S. Solomon (Boston, US)

Do we need trials to account for sex differences in HFpEF?

Speaker: Professor C. Lam (Singapore, SG)

What next for trials in heart failure with preserved ejection fraction? - discussion.

Access the full session

What next for trials in heart failure with preserved ejection fraction?

Speakers: Professor N. Sato, Professor S. Solomon, Professor C. Lam

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources